/
Andrew Low Lung Cancer Lead BRI Andrew Low Lung Cancer Lead BRI

Andrew Low Lung Cancer Lead BRI - PowerPoint Presentation

christina
christina . @christina
Follow
342 views
Uploaded On 2022-06-01

Andrew Low Lung Cancer Lead BRI - PPT Presentation

Navigation Bronchoscopy Case 1 Case 2 Case 3 Case 3 Case 3 Navigation bronchoscopy Uses CT imaging to create a 3D reconstruction Navigation bronchoscopy 201242 173185 Navigation ID: 913141

navigation case ptx bronchoscopy case navigation bronchoscopy ptx rate sensitivity resp safety reducing benign copd cost

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Andrew Low Lung Cancer Lead BRI" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Andrew LowLung Cancer Lead BRI

Navigation Bronchoscopy

Slide2

Case 1

Slide3

Case 2

Slide4

Case 3

Slide5

Case 3

Slide6

Case 3

Slide7

Slide8

Navigation bronchoscopy

Uses CT imaging to create a 3D reconstruction

Slide9

Navigation bronchoscopy

2012;4(2

):

173-185

Slide10

Navigation bronchoscopy

Slide11

Sensitivity?

1106 pts

19 studies

Sensitivity 0.82

(0.79-0.85)Specificity 1.00 (0.98-1.00)

Slide12

Safety?

Zhang et al 2015 - PTX rate of 5.9%Deng et al 2018 – PTX rate of 5.2%

Towe et al 2017 – 341 patients8.3% complication rate PTX 27 (7.5%) – 11 needed ICD, 16 observed

2 bleeds3 with resp failure64 – severe COPD, 114 – moderate COPD

Slide13

Cost effectiveness?

BMJ Open

Resp Res 2020;7

:e000595.Average cost of CT guided biopsy £1357 Nav Bronchosocpy

£1942-£2331

Slide14

Summary

Role in improving early diagnosisRole in reducing benign resectionsAnd presumably in reducing benign irradiationCost effectiveAcceptable diagnostic yield and safety

Slide15

Slide16

Slide17

Questions?